Menu

CME Corner

Active Programs

Patient-Centered Care in Advanced Prostate Cancer

Recommended treatment options for prostate cancer vary based on disease severity and life expectancy, with traditional approaches including active surveillance, surgery, radiation therapy, chemotherapy, and androgen deprivation therapy (ADT). Prostate cancer that progresses despite ADT is known as castration-resistant prostate cancer (CRPC). Until recently, the standard of care for CRPC patients w ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Clinical Insights in Pediatrics: Improving Asthma Control by Optimizing Pharmacotherapy, Monitoring, and Patient Education

Millions of children and their families are affected by asthma, the most common chronic illness of childhood and the third leading cause of hospitalization among children under the age of 15. Pediatricians and pediatric nurse practitioners are uniquely positioned to care for children and adolescents with asthma, as they are heavily involved in the assessment, management, and follow-up of these pat ...

  • i-Newsletter i-Newsletter
  • ACCME
  • NAPNAP

Advances in Severe Asthma Management: The Role of Biologics for Severe Asthma

Severe asthma is a heterogeneous condition that consists of multiple phenotypes. Roughly 10% of individuals with asthma experience poor control because they suffer from an underlying severe asthma pathophysiology characterized by airway inflammation resistant to conventional therapy. This activity will examine treatments tailored to various phenotypes. ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Advances in Severe Asthma Management: Understanding the Immunopathology of Uncontrolled Asthma

While poor asthma control is frequently attributed to poor adherence to prescribed medications and/or recommended environmental restrictions, 5% to 10% of patients experience poor control because they suffer from an underlying severe asthma pathophysiology characterized by airway inflammation resistant to conventional therapy. Severe asthma is a heterogeneous condition that consists of multiple ph ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Shared Decision Making in Selecting Initial MS Disease-Modifying Therapy
Next Question: Which Disease-Modifying Therapy Should I Try First?

This activity, the second in a 3-part series focused on shared decision making and patient-centered care in MS, will examine the differences in MS disease-modifying therapies (DMT) and provide guidance for working together with patients to select appropriate first-line treatment. ...

  • i-Newsletter i-Newsletter
  • ACCME
  • ANCC

Shared Decision Making at the Crossroads: Adjusting MS Therapy Next Question: When Is it Time to Adjust Therapy?

This activity, the third in a 3-part series focused on shared decision making and patient-centered care in MS, will examine how to assess outcomes of DMT therapy from both patient and clinician perspectives, as well as practical strategies for working with patients to adjust therapy when necessary. ...

  • i-Newsletter i-Newsletter
  • ACCME
  • ANCC

Motivational Interviewing to Support Shared Decision Making in MS
First Question: Should I Start Treatment?

This activity, the first in a 3-part series focused on shared decision making and patient-centered care in MS, will examine the practice of motivational interviewing (MI) and how it can help clinicians prompt patients to think about their diagnosis and therapeutic options. The management of MS is increasingly challenging due to the wide variation in the clinical course for each patient, an increas ...

  • i-Newsletter i-Newsletter
  • ACCME
  • ANCC

Clinical Insights in Pediatrics: Diagnosing and Managing Pediatric Epilepsy

In the United States, an estimated 460,000 children have active epilepsy, and approximately 750,000 children have a history of epilepsy. Epilepsy is a complex disorder that requires careful monitoring and management. Newer pharmacologic options for the treatment of focal and generalized seizures may provide more effective treatment options in the pediatric population. In addition to managing epile ...

  • i-Newsletter i-Newsletter
  • ACCME
  • NAPNAP

Assessing Psoriatic Arthritis Severity, Setting Goals, and Monitoring Progress

Psoriatic arthritis (PsA) is a chronic inflammatory arthritis associated with psoriasis. An estimated 7.5 million Americans have psoriasis, and an estimated 30% to 40% of individuals with psoriasis also develop PsA. Symptoms of PsA include fatigue, pain and inflammation in joints, and potentially progressive joint damage. Despite the availability of a variety of treatment options, many patients wi ...

  • Online Presentation Online Presentation
  • ACCME

Improving Patient Satisfaction with Psoriatic Arthritis Treatment

An estimated 7.5 million Americans have psoriasis, and an estimated 30% to 40% of individuals with psoriasis also develop psoriatic arthritis (PsA). Despite the availability of a variety of treatment options, many patients with PsA continue to experience suboptimal outcomes. This activity will examine tailoring therapy to maximize patient satisfaction. ...

  • Online Presentation Online Presentation
  • ACCME

Integrating Recently Approved Therapies into Psoriatic Arthritis Treatment Plans

Despite the availability of a variety of treatment options, many patients with psoriatic arthritis (PsA) continue to experience suboptimal outcomes. Recent research, however, has resulted in several newly approved and investigational agents that are likely to improve patient outcomes. This activity will examine recently approved and investigational therapies and their potential integration into tr ...

  • Online Presentation Online Presentation
  • ACCME

IBD Diagnosis and Management: Untangling the Complexities

Inflammatory bowel disease (IBD), which comprises ulcerative colitis (UC) and Crohnís disease (CD), is a complex condition that can be difficult to identify and treat. Carefully tailoring and monitoring care is essential because therapeutic goals and strategies differ by disease severity. New data available to clinicians are revising the management paradigm for IBD as well as the definition of dee ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Optimizing Asthma Control: Individualizing Therapy

This activity is the second in a 2-part interactive series titled "Point of Care Clinical Decisions in Asthma Management." Approximately 25.7 million Americans suffer from asthma, a chronic inflammatory disorder of the airways, resulting in recurrent episodes of airflow limitation, mucus production, and cough. Despite many effective therapies and recent advances, many patients continue to experien ...

  • Mobile + Online on RealCME Mobile + Online on RealCME
  • ACCME

Assessing Asthma Severity: A Self-Assessment and Clinical Overview

This activity is the first in a 2-part interactive series titled "Point of Care Clinical Decisions in Asthma Management." Approximately 25.7 million Americans suffer from asthma, a chronic inflammatory disorder of the airways, resulting in recurrent episodes of airflow limitation, mucus production, and cough. Despite many effective therapies and recent advances, many patients continue to experienc ...

  • Mobile + Online on RealCME Mobile + Online on RealCME
  • ACCME

Acute Heart Failure: Current Best Practices, Ongoing Challenges, and Future Directions

Each year, more than 1 million individuals are hospitalized for heart failure (HF). Within the spectrum of HF, acute heart failure (AHF) represents a distinct challenge to clinicians. Diagnosis of AHF is often delayed because of the complex characteristics of the condition. The heterogeneous nature of AHF patients and the presence of comorbid conditions can make it difficult for clinicians to reco ...

  • Online Presentation Online Presentation
  • ACCME

Targeting B-Cell Lymphomas: The Latest Updates in Therapies, Practice Strategies, and Clinical Research

The standards of care in treatment for non-Hodgkin lymphomas (NHL) are evolving as new therapies receive FDA approval and new evidence provides insight into optimal evidence-based approaches. Several key cellular pathways that drive malignant B-cell development have recently been identified and validated, leading to the development of therapies targeting these pathways. Agents targeting the B-cell ...

  • Online Presentation Online Presentation
  • ACCME

Diagnosis of PsA: Achieving an Accurate Assessment

Approximately 30% to 40% of people with psoriasis will also develop psoriatic arthritis (PsA), a painful and potentially disfiguring condition that remains underdiagnosed. Symptoms include fatigue, joint inflammation, and potentially progressive joint damage. This activity will examine the considerations for assessment and diagnosis of PsA. ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Management of Psoriatic Disease: Care and Ongoing Monitoring

Psoriatic arthritis (PsA) is underdiagnosed and undermanaged in the United States, and comorbidities that are often associated with PsA are sometimes overlooked. Many patients with PsA experience a significant emotional and physical impact from this condition despite an increase in options for successful treatment. This activity will examine the importance of early recognition and the consideratio ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Using GLP-1 Receptor Agonists to Reduce Cardiovascular Risk

The management of T2DM remains a major challenge as many patients continue to struggle with achieving therapeutic targets, including control of A1c levels, LDL cholesterol, and blood pressure. Glucagon-like peptide 1 (GLP-1) receptor agonists, one of the newer drug classes for the treatment of T2DM, may offer beneficial effects on cardiovascular risk factors. This activity will examine the use of ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Using GLP-1 Receptor Agonists to Optimize Glycemic Control

The management of T2DM remains a major challenge as many patients continue to struggle with achieving glycemic control. Glucagon-like peptide 1 (GLP-1) receptor agonists, one of the newer drug classes for the treatment of T2DM, have been shown to be safe and effective in improving glycemic control. This activity will examine the use of GLP-1 receptor agonists in clinical practice, including long-t ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Preventing Stroke in Atrial Fibrillation

Individuals with atrial fibrillation (AF) have a 4 to 5 times greater risk for ischemic stroke and tend to experience more serious strokes than those without AF. Although most strokes related to AF could be prevented with appropriate anticoagulation therapy, many patients are not receiving it. The goal of this activity is to help clinicians evaluate and optimally manage stroke risk in their patien ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Team-Based Approaches to Enhancing Care for Older Adults With T2DM

A collaborative and engaged style of care planning generally provides the best results for patients. Physicians, NPs, PAs, pharmacists, nurses, and others who care for and support older adults with type 2 diabetes (T2DM) can be most effective working in a team, especially when managing individuals with multiple chronic problems. This activity examines the key features of a holistic, relationship-b ...

  • i-Newsletter i-Newsletter
  • ACCME
  • ACPE
  • ANCC

Individualizing Treatment Plans for Older Adults with T2DM

Approximately 26% of adults over age 65 in the US (11.2 million people) have diabetes. This is a heterogeneous population that includes individuals residing independently in communities, in assisted living, and in skilled nursing facilities. Management of diabetes in older adults should be carefully tailored, taking into account these variables. All members of the care team, including physicians, ...

  • i-Newsletter i-Newsletter
  • ACCME
  • ACPE
  • ANCC

Perspectives on the Care of Older Adults with T2DM: A Multidisciplinary Discussion

This activity features an engaging multidisciplinary faculty discussion about special considerations in the care of older adults with T2DM. Many older adults with T2DM are experiencing negative health consequences that could be prevented or improved with optimal evidence-based care. This is a heterogeneous population that includes individuals residing independently in communities, in assisted livi ...

  • Video Roundtable Video Roundtable
  • ACCME
  • ACPE
  • ANCC

Improving Outcomes in Psoriasis: Exceeding Treatment Goals and Patient Expectations

This activity will address the management of psoriasis, including setting psoriasis treatment goals and monitoring treatment response to determine when adjustments to therapy are needed; developing tailored, evidence-based treatment regimens for individual patients; engaging patients in shared decision making for improved patient satisfaction; and considering clinical advances while developing tre ...

  • Online Presentation Online Presentation
  • ACCME

Progress Against Idiopathic Pulmonary Fibrosis

Idiopathic pulmonary fibrosis (IPF) is the most common idiopathic interstitial pneumonia, and its diagnosis and management remain a challenge in clinical practice. An expanding body of research on the pathogenesis of IPF, however, is leading to the identification of new therapeutic targets, and best practices are evolving with the emergence of new data and new therapies. This activity, which featu ...

  • Video Roundtable Video Roundtable
  • ACCME

Clinical Insights in Pediatrics (an i-Newsletter series)

Clinical Insights in Pediatrics (an i-Newsletter series) ...

  • Series
  • ACCME
  • NAPNAP

Expired Programs

12th Annual The Best of San Antonio: Breast Cancer - Bench to Bedside (Online Archive)

This critical review of results presented at the December 2014 San Antonio Breast Cancer Symposium includes neoadjuvant and adjuvant therapy, endocrine plus targeted strategies for early and metastatic disease, triple negative and anti-HER2 subtype updates, immune therapy, presurgical window trials, translational science, local-regional disease, prevention and survivorship. AGENDA New Direct ...

  • Online Presentation Online Presentation
  • ACCME

A Case Study in Monitoring and Managing Response and Resistance in CML

Chronic myeloid leukemia (CML) is a myeloproliferative disorder of the bone marrow, accounting for 15% of adult leukemias. Targeted therapy with tyrosine kinase inhibitors (TKIs) has dramatically improved 10-year overall survival for patients with CML from 20% to 80%-90%. To determine the best treatment approach for patients with CML, clinicians must thoroughly understand how to monitor treatment ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Achieving Optimal Outcomes in Patients With Inflammatory Bowel Disease

NOTE: This activity was presented as a live visiting faculty grand rounds series beginning on September 22, 2015. Participants who received credit for attending any of the live presentations are not eligible to receive credit for this online release. IBD is a chronic progressive inflammatory disorder of the GI tract, which includes Crohnís disease (CD) and ulcerative colitis (UC). CD and UC ar ...

  • Online Presentation Online Presentation
  • ACCME

Advances in Multiple Sclerosis: Current Best Practices, Ongoing Challenges, and Future Directions

An estimated 350,000 to 500,000 people in the United States are currently diagnosed with MS, a chronic neurologic disorder with potential for substantial negative impact on quality of life. Treatment is focused on returning function after an attack, preventing new attacks, and preventing disability. The management of MS is increasingly challenging due to heterogeneity in the pathogenesis of MS, wi ...

  • Video Roundtable Video Roundtable
  • ACCME
  • ANCC

Advances in Multiple Sclerosis: Optimizing Disease-Modifying Therapy

Multiple sclerosis is a chronic neurologic disorder with potential for substantial negative impact on quality of life. Treatment seeks to return function after an attack, prevent new attacks, limit disability progression, and improve quality of life. The management of MS is complex because of the variability in the clinical course for each patient, emerging therapies, and patient characteristics a ...

  • i-Newsletter i-Newsletter
  • ACCME

Anticoagulation Therapy for Stroke Prevention in Atrial Fibrillation

Nonvalvular atrial fibrillation (AF) is the most common sustained cardiac arrhythmia encountered in clinical practice and afflicts more than 3 million people in the United States. Individuals with AF have 4 to 5 times greater risk for ischemic stroke and tend to experience more serious strokes than those without AF. Although most AF-related strokes could be prevented with anticoagulation therapy, ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Case Challenges in Psoriasis and Psoriatic Arthritis

This case-based activity is the second activity in a larger curriculum (Improving Outcomes in Patients with Psoriasis and Psoriatic Arthritis) focusing on key aspects in the evidence- and guidelines-based diagnosis and treatment of patients with psoriasis and psoriatic arthritis. ...

  • Mobile + Online on RealCME Mobile + Online on RealCME
  • ACCME

Clinical Insights in Migraine Management: Evolving Approaches to Migraine Treatment and Adherence

Migraine affects between 11% and 16% of adults in the United States. This condition is associated with a significant societal and economic burden. There are many pharmacologic and nonpharmacologic treatment options for both chronic and episodic migraine, and clinicians should tailor these therapies to individual patient characteristics as well as disease severity and patterns. Additionally, patien ...

  • i-Newsletter i-Newsletter
  • ACCME

Clinical Insights in Migraine Management: State-of-the-Art Migraine Guidelines Review

Migraine affects between 11% and 16% of adults in the United States. This condition is associated with a significant societal and economic burden. On an individual level, chronic migraine is associated with reduced health-related quality of life and increased psychiatric and medical comorbidities. Guidelines provide definitions and diagnostic criteria for types of migraine and can aid clinicians i ...

  • i-Newsletter i-Newsletter
  • ACCME

Clinical Insights in Pediatrics: Early Detection and Optimal Treatment of Growth Disorders in Children

Approximately 10,000 to 15,000 children in the United States have problems with growth. Recombinant human growth hormone (GH) has been approved by the FDA for growth disorders in children. Though the FDA has specific indications for GH therapy, growth disorders are typically marked by either growth failure or short stature defined as 2 standard deviations or more below the normal mean for age and ...

  • i-Newsletter i-Newsletter
  • ACCME
  • NAPNAP

Clinical Review - Improving Outcomes in Patients with Psoriasis and Psoriatic Arthritis

This clinical review activity is the third activity in a larger curriculum (Improving Outcomes in Patients with Psoriasis and Psoriatic Arthritis) focusing on key aspects in the evidence- and guidelines-based diagnosis and treatment of patients with psoriasis and psoriatic arthritis. ...

  • Mobile + Online on RealCME Mobile + Online on RealCME
  • ACCME

Current Best Practices in the Management of Castration-Resistant Prostate Cancer

NOTE: This activity was presented as a live visiting faculty grand rounds series beginning on April 22, 2015. Participants who received credit for attending any of the live presentations are not eligible to receive credit for this online release. Among men in the United States, prostate cancer is the most common cancer and the second leading cause of cancer-related death. The recommended treat ...

  • Online Presentation Online Presentation
  • ACCME

Current Guidelines and Future Directions in Colorectal Cancer Treatment

NOTE: This activity was presented as a live visiting faculty grand rounds series beginning on April 16, 2015. Participants who received credit for attending any of the live presentations are not eligible to receive credit for this online release. Colorectal cancer (CRC) is the second leading cause of cancer death in America, causing roughly 50,000 US deaths annually. Although mortality from co ...

  • Online Presentation Online Presentation
  • ACCME

Defining, Diagnosing, and Treating Acute Heart Failure: Present Day Challenges

AHF represents a distinct challenge to clinicians. Diagnosis of AHF is often delayed because of the complex characteristics of the condition. The heterogeneous nature of AHF patients and the presence of comorbid conditions can make it difficult for clinicians to recognize the signs of AHF and provide optimal treatment. A paucity of data on AHF and a lack of agreement as to the parameters of the di ...

  • Video Roundtable Video Roundtable
  • ACCME

Improving Diagnostic Accuracy and Treatment Efficacy in Acquired Hemophilia: What Every Clinician Should Know

NOTE: This activity was presented as a live visiting faculty grand rounds series beginning on February 6, 2015. Participants who received credit for attending any of the live presentations are not eligible to receive credit for this online release. Acquired hemophilia (AH) is a rare but potentially life-threatening bleeding disorder caused by the development of autoantibodies directed against ...

  • Online Presentation Online Presentation
  • ACCME

Improving Outcomes in Patients with Psoriasis and Psoriatic Arthritis - A Self-assessment Program

This self-assessment is the first activity in a larger curriculum (Improving Outcomes in Patients with Psoriasis and Psoriatic Arthritis). The activity utilizes a question-and-answer format to review key aspects in the evidence- and guidelines-based diagnosis and treatment of patients with psoriatic arthritis. Following completion of this activity, learners will be directed to in-depth, case-ba ...

  • Mobile + Online on RealCME Mobile + Online on RealCME
  • ACCME

Improving Patient Outcomes in Chronic Myeloid Leukemia: Monitoring and Managing Response and Resistance

NOTE: This activity was presented as a live visiting faculty grand rounds series beginning on October 29, 2015. Participants who received credit for attending any of the live presentations are not eligible to receive credit for this online release. Chronic myeloid leukemia (CML) is a myeloproliferative disorder of the bone marrow, accounting for 15% of adult leukemias. Targeted therapy with ty ...

  • Online Presentation Online Presentation
  • ACCME

Improving the Diagnosis and Treatment of Acute Heart Failure

Diagnosis of AHF is often delayed because of the complex characteristics of the condition. The heterogeneous nature of AHF patients and the presence of comorbid conditions can make it difficult for clinicians to recognize the signs of AHF and provide optimal treatment. A paucity of data on AHF and a lack of agreement regarding the parameters of the disease state exacerbate this challenge. This int ...

  • i-Newsletter i-Newsletter
  • ACCME

Improving Women's Health Outcomes in MS: A Multidisciplinary Approach

Multiple sclerosis (MS) is a chronic neurologic disorder with potential for substantial negative impact on quality of life. MS is nearly 3 times more common in women compared with men and is typically diagnosed between the ages of 20 and 50. Since the diagnosis and treatment of MS frequently occur during womenís reproductive years, clinicians often face questions about MS treatment as it relates t ...

  • Video Roundtable Video Roundtable
  • ACCME

Opioid-Induced Constipation: Improving Outcomes With Individualized, Evidence-Based Treatment

This activity will review the safety and efficacy of available therapies to prevent and treat opioid-induced constipation. It will also examine strategies for optimizing treatment selection and adjusting therapy when necessary to help patients achieve their treatment goals and improve their overall quality of life. ...

  • Reach MD / podcast Reach MD / podcast
  • ACCME

Patient-Centered Care for Nonmotor Symptoms of Parkinson's Disease: Updates for Current Practice and Emerging Therapies

Approximately 1 million US adults have Parkinsonís disease (PD), a progressive neurodegenerative movement disorder that affects motor and cognitive function and significantly impairs quality of life. Nonmotor symptoms can significantly decrease quality of life for patients with advancing disease. These complications can include cognitive, neuropsychiatric, and autonomic symptoms. Available therapi ...

  • i-Newsletter i-Newsletter
  • ACCME

Patient-Centered Care in Early Parkinson's Disease: Updates for Current Practice and Emerging Therapies

Approximately 1 million US adults have Parkinsonís disease (PD), a progressive neurodegenerative movement disorder that affects motor and cognitive function and significantly impairs quality of life. PD can be difficult to diagnose, and it is critical that clinicians recognize symptoms, both motor and nonmotor, to aid in early and accurate diagnosis. Appropriate treatment initiation based on patie ...

  • i-Newsletter i-Newsletter
  • ACCME

Patient-Centered Care in Moderate to Advanced Parkinson's Disease: Updates for Current Practice and Emerging Therapies

Approximately 1 million US adults have Parkinsonís disease (PD), a progressive neurodegenerative movement disorder that affects motor and cognitive function and significantly impairs quality of life. Treatment of advancing disease can be complicated because clinicians must manage both motor deterioration and nonmotor symptoms. Long-term treatment carries significant complications that can exacerba ...

  • i-Newsletter i-Newsletter
  • ACCME

Reducing Hospital Readmission Rates for Patients with Acute Heart Failure

AHF represents a distinct challenge to clinicians. Mortality and readmission rates for patients with AHF remain high because hospital clinicians do not consistently adhere to guidelines for AHF management, discharge support, and education. This interactive newsletter will outline strategies for optimal management of this disease. ...

  • i-Newsletter i-Newsletter
  • ACCME

Stroke Prevention in Atrial Fibrillation: Current Evidence for Tailoring Antithrombotic Therapy

NOTE: This activity was presented as a live visiting faculty grand rounds series beginning on August 20, 2015. Participants who received credit for attending any of the live presentations are not eligible to receive credit for this online release. Nonvalvular atrial fibrillation (AF) is the most common sustained cardiac arrhythmia encountered in clinical practice and afflicts more than 3 milli ...

  • Online Presentation Online Presentation
  • ACCME
  • ANCC

Update on Treatment Strategies for Chronic Hepatitis C Virus Infection

THIS PROGRAM WAS ORIGINALLY PRESENTED AS A VISITING FACULTY GRAND ROUNDS SERIES THROUGHOUT THE COUNTRY, BEGINNING ON DECEMBER 3, 2014. IF YOU HAVE ALREADY RECEIVED CREDIT FOR ATTENDING ONE OF THE LIVE MEETINGS, YOU ARE INELIGIBLE TO RECEIVE CREDIT FOR THIS ENDURING ACTIVITY. Clinicians have an opportunity to improve outcomes for patients with chronic hepatitis C virus (HCV) infection by appropr ...

  • Online Presentation Online Presentation
  • ACCME

Updates in the Management of COPD: Diagnosis and Management

This activity will help clinicians achieve greater competency in accurately diagnosing COPD, assessing disease severity, and optimizing the use of nonpharmacologic and pharmacologic interventions in tailored COPD treatment plans. COPD is a slowly progressive respiratory disease characterized by airflow limitation that is not fully reversible. Manifestations of COPD include dyspnea, poor exercise t ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Updates in the Management of COPD: Managing Exacerbations

This activity will help clinicians achieve greater competency in managing exacerbations of COPD and optimizing the use of nonpharmacologic and pharmacologic interventions in tailored COPD treatment plans. ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Updating Clinical Practice in Rheumatoid Arthritis: Achieving Treatment Targets

The goal of this interactive newsletter is to expand the ability of physicians and other clinicians to implement best practices in the management of RA based on the latest clinical evidence. RA currently affects approximately 1.3 million people in the United States. Early treatment initiation, ongoing monitoring of therapeutic response, and appropriate treatment adjustments are critical to improvi ...

  • i-Newsletter
  • ACCME
Main Menu
EDITOR'S PICKS